In the field of biologic oxygenators, the use of autogenous lungs has been reported by Dodrill while Campbell recently has described a method of using heterologous lungs.
The feasibility of open intracardiac surgical technics with complete bypass of the heart and lungs in the treatment of congenital heart disease was first established by Gibbon Blood from the open chamber of the heart is collected continuously through a specially constructed sucker and returned under low vacuum to the pump-oxygenator along with the systemic venous return. In the 40 cases reported, 20 to 30 per cent and occasionally more of the venous return from the patient was from the open heart and the amount of flow through this intracardiac sucker system often was as much as 500 ml. per minute. If this blood were discarded, the loss would limit severely the time allowed for work within the opened heart unless impractically large quantities of blood were available. With the present system, a relatively clear operative field is obtained, which is not materially improved by temporarily cross-clamping the ascending aorta to stop coronary flow.
In contrast to the situation in the original Gibbon- operation. There are no moving parts and neither air nor oxygen is bubbled through the blood. The blood flows evenly and smoothly down the vertical screens on which respiratory exchange occurs (see Fig. 1 ) and collects in the arterial reservoir at the bottom of the oxygenator casing ready to be pumped back to the patient.
The pump-oxygenator is rendered a precision instrument by the incorporation in it of previously described automatic controls.'6 As a result of the interaction of these controls, the volume of blood within the pump-oxygenator is maintained at a constant amount and the blood returned to the patient is quantitatively equal to that leaving the patient to go to the unit. This is of obvious fundamental importance to safe extracorporeal circulation. As already indicated, the condition of the patient at the end of the perfusion perhaps is determined best by the ability of the heart and lungs to resume normal function. In the absence of abnormal rhythm, the heart always has taken over the circulation well after perfusion. Only one instance of ventricular fibrillation has occurred after extracorporeal circulation was discontinued. In this patient, it was considered immediately after perfusion that hypovolemia was present; as a consequence, citrated blood unwisely was introduced directly into the aorta. Ventricular fibrillation promptly occurred. Studies regarding hemolysis during extracorporeal circulation showed that values of less than 40 mg. of hemoglobin per 100 ml. of plasma were present in 38 of the 40 cases, including those in which perfusion was greatly prolonged. In two patients, values for plasma hemoglobin of 0.8 and 1.5 Gm. per 100 ml., respectively, were obtained at the end of the perfusion. However, analysis proved that even greater levels of plasma hemoglobin were present in the pooled blood before the machine was started. Excessive hemolysis of this nature apparently was related to methods of collection, pooling or preservation of the donor blood and has not been encountered since these two cases, both of which were in the early part of the series. Low levels of hemolysis indicate minimal damage to the blood. Determinations these cases factors other than the safety of the extracorporeal circulation enter into the mortality rate, perhaps the mortality figures in the treatment of ventricular septal defects do assist in the evaluation of this technic. Details of all but the last one of these 21 patients are published elsewhere.10 Suffice it to say that 15 of the 21 patients had severe pulmonary hypertension. The ages of these 21 patients ranged from 3 months to 29 years. All of them survived operation but four died in the postoperative period. The remaining 17 patients are well. It might be emphasized that only one death has occurred in the last 14 of this group of patients. One of the surviving patients is a 29-year-old man who was severely disabled before operation.
SUMMARY
The Gibbon-type pump-oxygenator has been used at the Mayo Clinic to maintain extracorporeal circulation of blood during intracardiac operations on 40 patients. It is concluded that this pump-oxygenator, used under proper circumstances, is a reliable and safe clinical tool in the intracardiac surgical repair of cardiac defects, BIBLIOGRAPHY
